Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19

NCT04716569 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: intranasal ivermectin spray

Sponsor

South Valley University